AKT1 and breast carcinoma: GSK1059615 on breast cancer cell lines in vitro inhibits the phosphorylation of Akt at S473, with an IC50 of 40 nM [55], which translates well to the cellular IC50 potency we find for the compound’s attenuation of signaling.